Revealing the Mechanisms of Byu dMar 25 in the Treatment of Alzheimer’s Disease through Network Pharmacology, Molecular Docking, and In Vivo Experiment

[Image: see text] Background: Alzheimer’s disease (AD) is the most common neurodegenerative disease, severely reducing the cognitive level and life quality of patients. Byu dMar 25 (BM25) has been proved to have a therapeutic effect on AD. However, the pharmacological mechanism is still unclear. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Yikuan, Guo, Jinyan, Zhou, Yuqi, Yan, Simin, Xu, Bijun, Wang, Yuni, Lu, Duoduo, Ma, Zhendong, Chen, Qianwen, Tang, Qibin, Zhang, Weichui, Zhu, Jinfeng, Huang, Yixing, Yang, Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357573/
https://www.ncbi.nlm.nih.gov/pubmed/37483184
http://dx.doi.org/10.1021/acsomega.3c01683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357573/
https://www.ncbi.nlm.nih.gov/pubmed/37483184
http://dx.doi.org/10.1021/acsomega.3c01683

Ejemplares similares